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Background: Bacillus subtilis is a very important Gram-positive model organism of high biotechnological relevance,
which is widely used as a host for the production of both secreted and cytoplasmic proteins. We developed a
novel and efficient expression system, based on the liaI promoter (PliaI) from B. subtilis, which is under control of the
LiaRS antibiotic-inducible two-component system. In the absence of a stimulus, this promoter is kept tightly
inactive. Upon induction by cell wall antibiotics, it shows an over 100-fold increase in activity within 10 min.
Results: Based on these traits of PliaI, we developed a novel LiaRS-controlled gene expression system for B. subtilis
(the “LIKE" system). Two expression vectors, the integrative pLIKE-int and the replicative pLIKE-rep, were constructed.
To enhance the performance of the PliaI-derived system, site-directed mutagenesis was employed to optimize the
ribosome binding site and alter its spacing to the initiation codon used for the translational fusion. The impact of
these genetic modifications on protein production yield was measured using GFP as a model protein. Moreover, a
number of tailored B. subtilis expression strains containing different markerless chromosomal deletions of the liaIH
region were constructed to circumvent undesired protein production, enhance the positive autoregulation of the
LiaRS system and thereby increase target gene expression strength from the PliaI promoter.
Conclusions: The LIKE protein expression system is a novel protein expression system, which offers a number of
advantages over existing systems. Its major advantages are (i) a tightly switched-off promoter during exponential
growth in the absence of a stimulus, (ii) a concentration-dependent activation of PliaI in the presence of suitable
inducers, (iii) a very fast but transient response with a very high dynamic range of over 100-fold (up to 1,000-fold)
induction, (iv) a choice from a range of well-defined, commercially available, and affordable inducers and (v) the
convenient conversion of LIKE-derived inducible expression strains into strong constitutive protein production
factories.
Keywords: two-component system, liaIH operon, antibiotic-inducible promoter, cell envelope stress response,
protein expression, Bacillus subtilis, bacitracinBackground
Bacillus subtilis is a widely exploited bacterium for basic
research, but also industrial and biotechnological appli-
cations [1] owing to the ease of genetic manipulation, a
systems level understanding of its genome and physi-
ology [2-4], its efficient protein secretion systems [5],
non-pathogenic GRAS-status [6] and well-characterized
mechanisms for gene expression [7]. Over the years,* Correspondence: mascher@bio.lmu.de
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distribution, and reproduction in any mediumnumerous genetic devices and expression systems have
been developed for this organism to facilitate the pro-
duction of homologous or heterologous proteins [7-14],
usually based on strong inducible promoters. Such sys-
tems can either be integrated into the chromosome or
located on replicative plasmids to increase the gene copy
number under the control of the inducible promoter.
A number of new expression systems based on induc-
tion by peptide antibiotics were described for Gram-
positive bacteria [9,15,16]. The nisin-controlled gene
expression (NICE) system was developed for different
species of Lactococcus and Lactobacillus and allows theentral Ltd. This is an Open Access article distributed under the terms of the
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(comparable to other expression systems), reaching a
maximum 3 h after nisin induction [15,16]. A very simi-
lar subtilin-regulated expression system (SURE) was re-
cently constructed for B. subtilis [9]. Both systems
enable the controlled overexpression of a variety of
homologous and heterologous proteins and enzymes
and show a number of advantages to other control ele-
ments, such as the strict control of gene expression, no
leakage of the promoter regulation under non-inducing
conditions, high levels of expression upon induction and
almost no limitations in the choice of sugar-containing
media [9,15]. For the use in B. subtilis, the SURE system
has several advantages over the NICE system: (i) The
SURE system only requires a single plasmid, thereby en-
suring a stable expression platform; (ii) the expression
levels achieved by the SURE system are significantly
higher; and (iii) it also requires lower concentrations of
the inducer molecule [9,17].
Despite significant progress in the field, no exisiting
system works equally well for all proteins and none of
the existing expression systems for B. subtilis is without
pitfalls or limitations. While the SURE system represents
a major improvement, its inducer, the lantibiotic subtilin,
is not commercially available. Instead, culture super-
natant of the lantibiotic producer must be used, which
introduces a source of variation and requires testing the
potency each time a new supernatant is used for induc-
tion. Therefore, novel tightly controllable gene expres-
sion systems are still in demand to expand and
complement the existing repertoire in order to find the
optimal solution for a given protein to be produced in B.
subtilis.
Here, such an addition to the existing bioengineering
toolbox for B. subtilis will be described. The LIKE (from
the German “LIa-Kontrollierte Expression”) system is
based on the cell envelope stress-responsive liaI pro-
moter. This promoter was initially identified in the
course of studies on the response of B. subtilis to the
presence of harmful concentrations of various cell wall
antibiotics [18]. The underlying regulatory network of
the cell envelope stress response in this organism is ra-
ther complex and consists of at least four extracytoplas-
mic function (ECF) σ factors and a similar number of
two-component systems (TCS) and has been extensively
studied [19,20]. One such TCS, LiaRS, is a central player
in the envelope stress response network of B. subtilis. It
strongly responds to antibiotics that interfere with the
lipid II cycle, such as bacitracin. Activation of the LiaRS
system of B. subtilis specifically leads to the strong in-
duction of a single target promoter, PliaI, which drives
the expression of the liaIH operon. This promoter is
basically shut off in the absence of inducing condition
during logarithmic growth and shows an impressivedynamic range of over 100- up to 1,000-fold in the pres-
ence of suitable stimuli [21-23].
Because of its specificity and sensitivity, PliaI has
already been developed as a powerful screening tool for
mechanism-of-action studies of novel peptide antibiotics
interfering with envelope integrity [22,24,25]. But its
tightly regulated, concentration-dependent and highly
dynamic behavior also makes this promoter a very
promising candidate for the development of a novel gene
expression system. This prospect is further supported by
transcriptome studies of mutants that are constitutively
switched Lia-ON or Lia-OFF, which revealed a very spe-
cific response with only very few genes being indirectly
affected [23]. Moreover, B. subtilis is highly resistant to
bacitracin, a commercially available compound, which
can be used as an ideal inducer to activate PliaI-driven
gene expression in growing cultures of B. subtilis. More-
over, a simple gene deletion can convert the inducible
into a high-level constitutive promoter activity. Based on
these traits of PliaI, we developed vectors and strains to
apply this promoter as a powerful protein expression
system in B. subtilis.Results and discussion
Features of the native liaI promoter (PliaI)
Previously, we have characterized the cell envelope
stress-inducible promoter PliaI, which controls the ex-
pression of the liaIH operon in B. subtilis. During nor-
mal logarithmic growth, this promoter is virtually
switched off and hence does not show any significant
basal activity. In the presence of suitable inducers such
as the cell wall antibiotic bacitracin, it strongly responds
in a concentration-dependent manner, resulting in a
more than 100-fold increased activity already 5–10 min
after the addition of bacitracin. This activity strictly
depends on the activity of the response regulator LiaR
[21-23] (Figure 1A). This tight regulation and the im-
pressive strength of PliaI under inducing conditions are
illustrated by the protein gel shown in Figure 1B, which
demonstrates that even from the native PliaI, present in
single copy on the chromosome, LiaH is the predomin-
ant protein produced under inducing conditions, as has
already been indicated previously by 2D gelectrophoresis
[23]. These features make PliaI a very promising candi-
date for developing a novel protein-expression system
for the Gram-positive model organism B. subtilis, which
is widely used in the biotechnological industry as a pro-
tein production host [1]. To achieve this, the liaI pro-
moter was first sequence-optimized and then integrated
into two expression vectors. Moreover, a set of suitable
expression strains was developed and evaluated to fur-
ther improve the promoter strength while simultan-
eously avoiding the metabolic burden of overexpressing
Figure 1 Activity of the native liaI promoter (PliaI) as monitored
by (A) promoter-reporter gene fusions and (B) SDS-PAGE.
(A) β-Galactosidase reporter assays of a PliaI-lacZ fusion in the wild
type W168 (TMB016) and the corresponding liaF and liaR mutants
(TMB331 and TMB020, respectively) in the presence and absence of
bacitracin (Bac; final concentration 50 μg/ml). The assay was
performed as previously described [21], the promoter activity is
expressed as Miller units (β-galactosidase activity normalized against
cell density). (B) SDS-PAGE of the soluble protein fraction (15 μg/lane)
of the wild type (WT) and isogenic liaF and liaR mutants,
challenge for 30 min with bacitracin as described above. The
position of the band corresponding to the LiaH protein is marked. The
identity of LiaH was verified by mass spectroscopy. M, molecular
weight markers.
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lation, LiaI and LiaH [23], as indicated in Figure 1B.
Design and construction of PliaI-based expression vectors
and B. subtilis protein production strains for the LIKE
system
A closer inspection of the liaI promoter sequence
revealed a poorly conserved Shine-Dalgarno sequence
(SD) with a suboptimal spacing to the liaI start codon
(data not shown). As a first step in developing a PliaI-derived bacitracin-inducible expression system, we
therefore optimized its SD sequence by introducing a
strong B. subtilis ribosome binding site (TAAGGAGG)
with an optimal spacing of seven nucleotides upstream
of the start codon, which was used for all subsequent
constructions and will be referred to as PliaI(opt) from
now on (Figure 2). This optimized SD sequence is well
established for B. subtilis [26,27], and provides optimal
complementarity to the 3’-end of the 16S rRNA, thereby
increasing the ribosome’s affinity to the mRNA and en-
hancing the translation initiation efficiency.
For the construction of new PliaI-derived bacitracin-
inducible gene expression systems, we chose two vectors
as backbones: the E. coli/B. subtilis shuttle vector
pGP380, and pDG1662 for ectopic integration at the
amyE locus of B. subtilis [28,29], thus enabling both ex-
pression from a multi-copy replicative vector, as well as
the stable chromosomal integration at single copy. The
optimized regulatory element PliaI(opt) was amplified by
PCR and cloned into the two vectors (see Materials and
Methods for details) resulting in the expression vectors
pLIKE-rep and pLIKE-int, respectively (Figure 2A/B).
Previous work has demonstrated that the liaIH operon
is the only relevant target of LiaFSR-dependent gene ex-
pression, and that activation of PliaI results in a strong
accumulation of LiaH in the cytosol (Figure 1B) [23].
Based on the organization and expression of genes in
the liaIH-liaGFSR locus, activation of PliaI also leads to
an increased expression of liaGFSR, due to read-through
transcription [22]. Such positive autoregulatory feedback
loops often have beneficial effects on the activity of their
target genes [30]. Hence, it might be desirable to main-
tain this feedback loop. On the other hand, the observed
very strong production of the native LiaFSR-target pro-
teins LiaIH is not desired in a protein production host,
since it depletes the cells of energy, amino acids and
ribosomes required for heterologous protein production.
To account for these two opposing goals, we con-
structed a number of clean deletion mutants as potential
hosts of the LIKE-system. The features of the resulting
strains are summarized in Figure 2C. Strain TMB604
lacks both the liaIH operon including the native liaI
promoter. Hence, no autoregulation can occur under in-
ducing conditions. In contrast, strains TMB1151/
TMB1152, which are also deleted for the liaIH operon,
still maintain PliaI and therefore autoregulation. They
differ in the presence or absence of the weak terminator
located downstream of liaH (Figure 2C).
As a measure for PliaI(opt)-dependent protein produc-
tion in the two expression plasmids, gfpmut1 gene was
used as a reporter gene [31]. Translational fusions of
PliaI(opt) with gfpmut1 were constructed in both pLIKE-
int and pLIKE-rep and subsequently introduced into the
aforementioned B. subtilis strains.
(A) (B) 
PliaI PliaG 




liaG             liaF                 liaS                liaR 
PliaI PliaG 
Bsu-LIKE1 
(TMB1151) liaG             liaF                 liaS                liaR 
PliaI PliaG 




              ClaI          BamHI                        HindIII                         EcoRI     
   pLIKE-int  ...CGTAAGGAGGATCATCGATG GAT CCT AGA AGC TTA TCG AAT TC... 
                                                   strong  SD             XbaI               SalI                PstI               SphI             HindIII     
pLIKE-rep ...CGTAAGGAGGATTCTAGAGT CGA CCT GCA GGC ATG CAA GCT T... 
Figure 2 Vectors and strains of the LIKE system. (A) Vector maps of integrative plasmid pLIKE-int and E. coli/B. subtilis shuttle vector pLIKE-rep.
Abbreviations: PliaI(opt), liaI promoter with optimized SD sequence; bla, ampicilin resistance; erm, erythromycin resistance; cat, chloramphenicol
resistance; ColE1, origin of replication for E. coli; ori1030, origin of replication for B. subtilis. (B) Sequence of the multiple cloning sites for each
plasmid. The optimized SD sequence is indicated in bold, the 7 bp ‘spacer’ is boxed, the first nucleotide of the coding sequence is underlined.
For pLIKE-int, ClaI can be used as restriction enzyme to create an ATG start codon. For pLIKE-rep, XbaI must be used to reconstruct the ATG start
codon. (C) Schematic representation of the liaI operon and genotype of deletion strains constructed in this study. Open reading frames are
depicted as solid arrows. Promoters of the genes indicated by thin arrows, terminators by hairpin symbols.
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induced GFP production
The range of inducers for the envelope-stress responsive
LiaFSR three-component system is well-defined and
includes, amongst others, the cell wall antibiotic bacitracin
[22,25]. As an inducer for protein production in B. subtilis,
this compound has a number of advantages: (i) It is one of
the strongest inducers for the Lia-system and is easily
commercially available. (ii) B. subtilis is highly resistant
against bacitracin, and even above inhibitory antibiotic
concentrations, cellular damage occurs only very slowly
[18,32]. (iii) The maximum PliaI activity occurs well below
the inhibitory concentration, thereby avoiding any damage
to the producing cultures. (iv) In addition to its major in-
hibitory activity on cell wall biosynthesis, bacitracin also
acts as a weak protease inhibitor [33], which can be
viewed as a beneficial side effect of using this inducer. For
all of these reasons, bacitracin will be used as the model
inducer for the subsequently described evaluation of the
LIKE expression system.Nevertheless, it should be pointed out that a number
of other compounds and conditions can also be consid-
ered as suitable alternative inducers, including antibio-
tics such as vancomycin or nisin, as well as non-
antibiotic conditions such as alkaline shock [34], making
the LIKE-system highly variable even in cases where
bacitracin is not suitable for a given application (for ex-
ample for heterologous protease production).
Initially, we compared the promoter activity of PliaI(opt)
between pLIKE-int and pLIKE-rep in all four different
host strains described above (Figure 2C). For this pur-
pose, the dynamics of expression of recombinant GFP
was determined after bacitracin addition (30 μg mL-1)
over the course of 4 h in growing populations. In all
strains, a swift and strong accumulation of fluorescence
was detected already 30 min after bacitracin induction
(Figure 3A). As expected, gfp expression was signifi-
cantly higher in strains harboring the replicative pLIKE-
rep derivative (multiple copies) compared to strains
with chromosomally integrated pLIKE-int derivatives
Figure 3 Growth, absolute fluorescence (A) and promoter activity (B) of strains carrying translational fusion of PliaI-gfpmut1 and PliaI
(opt)-gfpmut1. Growth profiles are shown without symbols and expression by symbols: (○) (W168), (□) (TMB604), (◊) (TMB1151), (Δ) (TMB1152)
and (●) (TMB408). Vertical dotted line indicates time point of bacitracin addition (final conc. 30 μg mL-1; OD600~0.4-0.5). Fluorescence is expressed
in arbitrary units (AU) (C) Western blot analysis of the cytoplasmic fractions of cells expressing the same fusions probed with LiaH or GFP antisera.
Lanes 1–2, protein expression with native modified PliaI; 3–10, with optimized PliaI(opt) in the absence (−) and presence (+) of bacitracin (final conc.
30 μg mL-1).
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fluorescence intensity of the expression strain TMB1172,
harboring the integrated expression plasmid, reached
less than 10% of the activity measured for the other-
wise identical strain TMB1176 with the replicative
construct (Figure 3A).
The benefit of improving the ribosome binding site in
PliaI(opt) compared to the original SD sequence could
also be demonstrated by comparing GFP production in
two strains, TMB1172 and TMB408, respectively, har-
boring integrated expression systems. Our analysisrevealed that the level of GFP expression from the wild
type PliaI promoter in strain TMB408 was significantly
lower compared to PliaI(opt)-mediated expression
(Figure 3A and Figure 3C, lanes 2 and 4). A deletion of
the native PliaI upstream of the liaGFSR operon in strain
TMB604 resulted in an approx. two-fold decreased pro-
moter activity compared to the wild type background,
indicating that the presence of the autoregulatory feed-
back loop is important for full PliaI activity (Figure 3A
and Table 1). On the other hand, deletion of liaH while
maintaining the native PliaI upstream of the liaGFSR
Table 1 Effect of mutations in the liaIH operon on the expression of translational PliaI(opt)-gfp fusions
Strain Relevant genotypea Promoter activity
(fluorescence)bExpression plasmid Strain background
TMB408 amyE:: pSJ5101 (PliaI-gfp) (WT168) PliaIliaIHTerm
+ 264
TMB1172 amyE:: pLIKE-int+gfp (WT168) PliaIliaIHTerm
+ 1440
TMB1174 (TMB604) ΔPliaIliaIH 958
TMB1153 (TMB1151) ΔliaIH 1080
TMB1318 (TMB1152) ΔliaIHTerm 1416
TMB1176 pLIKE-rep+gfp (WT168) PliaIliaIHTerm
+ 9570
TMB1178 (TMB604) ΔPliaIliaIH 3372
TMB1342 (TMB1151) ΔliaIH 10607
TMB1343 (TMB1152) ΔliaIHTerm 10870
a The terminator downstream of liaH is abbreviated “Term”, its presence is indicated by a “+”. b Promoter activities were calculated taking the derivative of the
fluorescence divided by the OD600 (dGFP/dt/OD600) at each time point.
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increase of PliaI(opt) activity in case of the pLIKE-int
derived expression strain. This effect was more pro-
nounced in case of the pLIKE-rep derived strains, where
the promoter activity even surpassed that of the wild
type (Figure 3A and Table 1). Taken together, these
results demonstrate both the important role of the auto-
regulatory feedback and of improving the SD sequence
for achieving a maximal level of GFP production.
Determination of the PliaI activity revealed that the
window of promoter activity was narrower in case of the
integrated promoter, both for activation and shut-off,
relative to the replicative derivatives (Figure 3B). For the
pLIKE-int derivatives, maximum promoter activity was
reached already 20–30 min after addition of bacitracin
and the total window of activity was less than 60 min. In
contrast, pLIKE-rep derivatives required almost 60 min
to reach maximum promoter activity and the total win-
dow of activity was about 120 min. But in light of the
overall 10-times higher promoter activity in case of the
latter, this result is maybe not too surprising.
All major conclusions drawn above were verified at
the protein level by Western analysis, using antibodies
against GFP and LiaH. Both proteins were not detectable
in uninduced cultures, supporting the previously demon-
strated tight control of PliaI and the absence of any sig-
nificant promoter activity under non-inducing conditions.
Upon addition of bacitracin, both proteins accumulated to
different level, depending on strain background. These
studies demonstrate both the positive effect of improving
the ribosome binding site and the negative effect of delet-
ing the autoregulatory feedback loop at the level of protein
production (Figure 3C).
Taken together, both pLIKE-int and pLIKE-rep were
successfully established as vectors for bacitracin-
dependent protein production in strains that maintain
the positive autoregulatory feedback loop. Whileexpression based on the replicative vector yields
higher protein amounts, the integrative system has the
advantage of genetic stability and does not require any
selection.
Effect of the inducer (bacitracin) concentration on the
activity of PliaI(opt)
Next, we wanted to investigate the dynamics of PliaI ac-
tivity and the resulting GFP production as a function of
the inducer concentration. It is already well established
that PliaI-mediated gene expression occurs in a dosage-
dependent manner, at least in case of the wild type pro-
moter [22,23,32]. Here, we performed similar experi-
ments, using the pLIKE-int and pLIKE-rep derivatives
pAT6203 and pAT3803, respectively, in the W168 (wild
type) background. The resulting strains TMB1172 and
TMB1176 were inoculated in microtiter plates and
challenged in the mid-exponential growth phase with
increasing concentrations of bacitracin (Figure 4). The
results are in very good agreement with the previous
observations. The promoter activity increases as a func-
tion of the bacitracin concentration, reaching a max-
imum at bacitracin concentrations of about 30 μg mL-1
(Figure 4A/B). At higher concentrations (above 50 μg
mL-1), the ongoing promoter activity after 250 mins
indicates an ongoing bacitracin stress. Especially at the
highest bacitracin concentration, 100 μg mL-1, the GFP
yield is clearly reduced concomitant with a reduced
final cell density, at least in case of the pLIKE-rep
derived strain TMB1176 (Figure 4A). This result was
also confirmed by Western blot analysis (Figure 4C).
To ensure optimal protein production without causing
severe antibiotic stress, our data suggests the use of a
bacitracin concentration of no more than 30 μg mL-1,
although this concentration may have to be optimized
for individual target proteins, especially if toxicity is a
problem.
Figure 4 Concentration-dependent induction of the PliaI(opt) in B. subtilis W168 cultures. (A) Growth, absolute fluorescence and (B)
promoter activity of strains carrying translational fusion of PliaI(opt)-gfpmut1 on plasmids pLIKE-int and pLIKE-rep treated with different
concentration of bacitracin. Growth profiles are shown without symbols and expression by symbols: (◊) 1 μg mL-1, (□) 3 μg mL-1, (■) 10 μg mL-1,
(○) 30 μg mL-1, (●) 50 μg mL-1, (Δ) 100 μg mL-1. Vertical dotted line indicates the point of mid-log phase (OD600~0.4-0.5) when bacitracin was
added. Fluorescence is expressed in arbitrary units (AU) (C) Western blot analysis revealed the amount of GFP produced by cells harboring
pAT6203 (pLIKE-int) and pAT3803 (pLIKE-rep) 90 min post induction.
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To demonstrate the suitability of the LIKE system for
the overexpression of a heterologous protein, we per-
formed an expression experiment using the protein
YdfG of Bacillus licheniformis. This protein is a putative
carboxymuconolactone decarboxylase. We could re-
cently demonstrate that its gene represents the only tar-
get of the extracytoplasmic function σ factor ECF41Bli
[35]. It consists of 148 amino acids and an estimated
molecular weight of 16,6 kDa.
Based on the results shown in Figures 3 and 4, we
used strains TMB1151 and TMB1152 as expression
hosts for the pLIKE-rep+His6-ydfG (pKSLIKEr01) and
pLIKE-int+His6-ydfG (pKSLIKEi01) derivative, respect-
ively. YdfG production was induced in mid-log growingcultures by addition of 30 μg ml-1 bacitracin. The cells
were harvested 30 min post-induction and disrupted by
sonication. For each sample, 10 μg of total protein was
separated on a 14% tricine gel and subsequently stained
by colloidale Coomassie staining solution. The result is
shown in Figure 5. For both derivatives, a clear add-
itional band can be observed in the induced fractions at
~17 kDa. As expected, the YdfG yield received from the
pLIKE-rep derivative is much higher compared to the
integrative one. To be sure that this band is not a baci-
tracin effect, control samples of the expression host
TMB1151 were treated equally and were also loaded on
the gel. Here, no distinct band can be observed in the
bacitracin-induced sample (Figure 5). By using the
pLIKE-rep derivative, it was possible to achieve a protein
Figure 5 Overproduction of YdfG using the LIKE system. 14%
tricine SDS-PAGE of total proteins (10 μg/lane) of strains TMB1566
(YdfG-rep), TMB1570 (YdfG-int), and TMB1151 (control) treated with
and without 30 μg ml-1 bacitracin for 30 min. The position of the
band corresponding to the protein YdfG is marked. M, molecular
weight marker (in kDa).
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bacitracin-induced B. subtilis wild type cells (Figure 1B).
Conclusions
We have developed a novel and efficient LiaFSR-
dependent gene expression system, which places target
proteins under the control of an optimized bacitracin-
responsive PliaI promoter. The LIKE system offers first a
single-copy, integrative option (pLIKE-int in strain Bsu-
LIKE2), which is genetically stable without selective
pressure, but reaches lower protein production levels.
The second option consists of the replicative vector
pLIKE-rep in combination with strain Bsu-LIKE1 to ob-
tain a maximum gene expression. The LIKE-system has
a number of important features: (i) There is no detect-
able background expression in the non-induced state.
(ii) Using bacitracin as inducer, the promoter has an im-
pressive dynamic range of up to 1,000-fold above back-
ground level that can be titrated as a function of inducer
concentration. (iii) The described range of inducers is
wide, including cell wall antibiotics that function as
strong (bacitracin, nisin, daptomycin) or intermediately
strong (vancomycin) inducers, as well as non-antibiotic
conditions that act as intermediate to weak inducers of
the Lia-system, including pH-upshift, organic solvents,
some detergents, or ethanol [22,25,36-38]. All of these
inducers are well-defined and readily available at low
prices. Moreover, a recent study demonstrated that theLia-system can also be induced by the overexpression of
certain heterologous and secreted proteins, especially
the universal shock protein USP45 from Lactococcus lac-
tis and the TEM-1 β-lactamase from E. coli [39]. (iv)
Lastly, an antibiotic-inducible LIKE-expression strain
can easily be converted into a strong constitutive expres-
sion platform by the simple deletion of liaF, encoding
the LiaRS-specific inhibitor protein [21-23]. The effect
of such a deletion is shown in Figure 1, which demon-
strates that a liaF deletion results in a protein produc-
tion that even surpasses that of the fully induced strains,
even in the absence of an inducer.
This flexibility distinguishes the LIKE system from
other available expression systems. Taken together, the
expression vectors and strains described in this report
expand the genetic toolbox already available for protein
production, based on the tight and highly dynamic
bacitracin-inducible promoter PliaI. We hope and believe
that the vectors and strains described in this report will
provide valuable tools for protein expression in
B. subtilis. The LIKE system, consisting of both expres-
sion vectors as well as the host strains Bsu-LIKE1 and
Bsu-LIKE2, is available for the scientific community
through the Bacillus Genetic Stock Center (www.bgsc.
org; accession numbers ECE255, ECE256 for the two
vectors and 1A1070, 1A1071 for the two B. subtilis ex-
pression strains).Methods
Growth conditions
All bacterial strains (Table 2) were grown in Luria–
Bertani (LB) medium at 37°C with aeration. The cell
density was determined by measuring the OD600 with the
Ultrospec™ 2100 pro UV/visible spectrophotometer (GE
Healthcare). When appropriate, the growth media were
supplemented with chloramphenicol (5 μg mL-1),
erythromycin (1 μg mL-1) plus lincomycin (25 μg mL-1)
for macrolide-lincosamide-streptogramin (MLS) resist-
ance (B. subtilis), or ampicillin (100 μg mL-1; E. coli).
Protein expression was induced by using zinc bacitracin
(Sigma).DNA manipulations, transformation and PCR
All plasmid constructions were done in E. coli and iso-
lated by alkaline lysis method [40], then used to trans-
form B. subtilis [41]. Procedures for DNA manipulation
and transformation of E. coli were carried out as
described [42]. The primers used in this study are listed
in Table 3. For all PCR reactions the Phusion DNA Poly-
merase (Finnzymes) was used according to the manufac-
turer’s instructions. Sequencing was performed in-house
by the Sequencing Facility of the LMU Biocenter.
Table 2 Bacterial strains used in this study
Strain Relevant genotype Source and/or reference
E. coli DH5α recA1 endA1 gyrA96 thi hsdR17(rK
- mK
+) relA1 supE44 φ80ΔlacZΔM15 Δ(lacZYA-argF)U169 Laboratory stock
Bacillus subtilis
W168 Wild type, trpC2 Laboratory stock
HB0933 W168 attSPβ2Δ2 trpC2, liaR::kan [18]
TMB016 W168 amyE::(cat PliaI-lacZ) [21]
TMB020 HB0933 amyE::(cat PliaI-lacZ) [21]
TMB329 W168 ΔliaF (clean deletion) [23]
TMB331 TMB329 amyE::(cat PliaI-lacZ) This work
TMB408 W168 amyE::pSJ5101 (PliaI-gfp) S. Jordan
TMB604 W168 ΔPliaI-liaIH (clean deletion) [23]
Bsu-LIKE1 (TMB1151) W168 ΔliaIH (clean deletion) This work
Bsu-LIKE2 (TMB1152) W168 ΔliaIH-terminator (clean deletion) This work
TMB1172 W168 amyE::pAT6203 (pLIKE-int PliaI(opt)-gfp) This work
TMB1176 W168 pAT3803 (pLIKE-rep PliaI(opt)-gfp) This work
TMB1174 TMB604 amyE::pAT6203 (pLIKE-int PliaI(opt)-gfp) This work
TMB1178 TMB604 pAT3803 (pLIKE-rep PliaI(opt)-gfp) This work
TMB1153 TMB1151 amyE::pAT6203 (pLIKE-int PliaI(opt)-gfp) This work
TMB1342 TMB1151 pAT3803 (pLIKE-rep PliaI(opt)-gfp) This work
TMB1318 TMB1152 amyE::pAT6203 (pLIKE-int PliaI(opt)-gfp) This work
TMB1343 TMB1152 pAT3803 (pLIKE-rep PliaI(opt)-gfp) This work
TMB1566 TMB1151 pKSLIKEr01 (pLIKE-rep PliaI(opt)-His6-ydfG) This work
TMB1570 TMB1152 pKSLIKEi01 (pLIKE-int PliaI(opt)-His6-ydfG) This work
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Several markerless deletions of the liaIH operon (includ-
ing its promoter and terminator) were constructed using
the vector pMAD [43]. Genomic regions of approxi-
mately 1 kb up- and downstream of the regions to be
deleted were amplified using the primers listed in
Table 3. The two fragments were fused in a second join-
ing PCR reaction, and the resulting fragment was cloned
into pMAD via BamHI and EcoRI, generating the plas-
mids pAT101 (ΔliaIH) and pAT102 (ΔliaIHTerminator).
For generating the deletion mutants, the procedure
described by Arnaud et al. was applied [43]. In brief, B.
subtilis 168 was transformed with pAT101 or pAT102
(Table 4) and incubated for two days at 30°C on LB agar
plates containing X-Gal (5-bromo-4-chloro-3-indolyl-β-
D-galactopyranoside; 100 μg mL-1) with MLS selection.
Individual blue colonies were selected and incubated for
6 to 8 h at 42°C in LB medium with MLS selection,
resulting in the integration of the plasmids into the
chromosome. Blue colonies were again picked from LB
(X-Gal) plates and incubated at 30°C for 6 h in LB
medium without selection. Subsequently, the liquid cul-
ture was shifted to 42°C for 3 h, and the cells were then
plated on LB (X-Gal) plates, this time without selective
pressure. White colonies that had lost the plasmids werepicked and checked for MLS sensitivity. Finally, strains
TMB1151 (ΔliaIH) and TMB1152 (ΔliaIHTerminator)
were analyzed by PCR and sequencing to confirm the in-
tegrity of the desired genetic modifications.
Plasmid and strain construction
Bacterial strains used in this study are derivates of the
laboratory wild type strain B. subtilis W168 and are
listed in Table 2. Plasmids used in this study are listed in
Table 4. The promoter of the liaIH operon for integra-
tive and replicative vectors was obtained from strain B.
subtilis W168 by PCR, using primers TM2064/TM1980
and TM1991/TM1992 (Table 3), respectively. During the
amplification, bases in the ribosome-binding site (RBS)
were mutated to a strong B. subtilis Shine-Dalgarno
(SD) sequence (TAAGGAGG) [27] to yield the opti-
mized liaI promoter PliaI(opt).
The integrative expression vector pLIKE-int, contain-
ing PliaI with an optimized SD site (PliaI(opt)) was gener-
ated in two steps. First, the B. subtilis integrative vector
pDG1662 was treated with BstBI to remove the spec-
tinomycin resistance gene. The truncated (6141 bp) frag-
ment was self-ligated, yielding vector pAT6200. During
this step, the multiple cloning site (MCS), containing
unique BamHI, HindIII, and EcoRI sites was expanded
Table 3 Oligonucleotides used in this study
Primers Sequence (5' to 3')a Description/position
Plasmid construction
TM2064 CATGGTCTCAGATCTTTAAAACGCCATGCCTCG BsaI; 5' end of PliaI
TM1980 CTTGTTGGATCCATCGATGATCCTCCTTACGTTTTCCTTGTCTTC Strong SD region; BamHI, ClaI; 3' end of PliaI
TM1991 ATCTGAATTCGGTTTTAAAACGCCATGCC EcoRI; 5' end of PliaI
TM1992 ATTTTCTCTAGAATCCTCCTTACGTTTTCCTTGTCTTC Strong SD region; XbaI; 3' end of PliaI
TM1981 TCCTATCGATGAGTAAAGGAGAAGAACTTTTCACTGG ATG start codon; ClaI; 5' end of gfpmut1
TM1982 GGCCAAGCTTGAACTAGTTTCATTTATTTGTAGAGC HindIII; 3' end of gfpmut1
TM1993 TTCCTCTAGATGAGTAAAGGAGAAGAACTTTTC ATG start codon; XbaI; 5' end of gfpmut1
TM1994 GGCCGTCGACGAACTAGTTTCATTTATTTG SalI; 3' end of gfpmut1
TM2535 CCATATCGATGCATCATCATCATCATCACGAAACGAGATTTCTAATGGAAAAAG ATG start codon; ClaI; His6-tag; 5’ end of ydfG
TM2536 CCATAAGCTTTCAATCTGCTGCGGGCATTTTC HindIII; 3’ end of ydfG
TM2545 CCATTCTAGATGCATCATCATCATCATCACGAAACGAGATTTCTAATGGAAAAAG ATG start codon; XbaI; His6-tag; 5’ end of ydfG
Clean deletions
TM2130 GCGGGGATCCTCTTACATTTATTAGTCC BamHI; upstream of PliaI
TM2131 CATTTGCCGCTTTTGTCTGGGCAGATCCTCCTTTCGTTTTC 3' end of PliaI; 3' end of liaH
TM1055 CCAGACAAAAGCGGCAAATG 3' end of liaH
TM1058 CCATGAATTCGAATGCGGACGTCCGTCACGC EcoRI; inside the liaG gene
TM2132 GCGAATTGATACGTGCGGGCAGATCCTCCTTTCGTTTTC upstream of liaI gene; upstream of liaG
TM2133 CCGCACGTATCAATTCGC upstream of liaG
TM2134 GCTAGAATTCTGCCGGCTGTTTTGGAG EcoRI; center of liaG gene
a Relevant restriction sites are shown in italics, complementary regions for joining PCR are underlined. The sequence for optimized SD sequences of the liaI
promoter is indicated by bold type, the start codon is bold italic. The His-tags are in italics and underlined.
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required for introducing genes at the ATG start codon
(see Figure 2 for details): a PCR product encompassing
PliaI(opt) was digested with BsaI and BamHI and cloned
into pAT6200 digested with BamHI, resulting in pLIKE-
int. The ClaI restriction site is recommended to use for
reconstruction of the ATG start codon, but it is notTable 4 Vectors and plasmids used in this study
Plasmid Genotype/properties a
pDG1662 cat, spc, bla, amyE' . . . 'amyE integrative vector
pGP380 erm, bla, Strep-Tag, PdegQ36, replicative vector
pMAD erm, ori(pE194-Ts), MCS-PclpB-bgaB, ori(pBR322), bla
pSG1151 bla, cat, gfpmut1
pAT6200 pDG1662 derivative; spc gene deleted
pLIKE-int pAT6200 derivative; PliaI(opt); integrative protein expressio
pLIKE-rep pGP380 derivative; PliaI(opt); replicative protein expression
pAT6203 pLIKE-int, PliaI(opt) translationally fused to gfp
pAT3803 pLIKE-rep, PliaI(opt) translationally fused to gfp
pAT101 pMAD ΔliaIH up/down overlap
pAT102 pMAD ΔliaIHTerminator up/down overlap
pKSLIKEr01 pLIKE-rep, PliaI(opt) translationally fused to His6-ydfG
pKSLIKEi01 pLIKE-int, PliaI(opt) translationally fused to His6-ydfG
a Resistance cassettes: erm, erythromycin; bla, ampicillin; cat, chloramphenicol; spc,strictly necessary. The use of BamHI, HindIII, or EcoRI
has the disadvantage of fusing additional amino acids to
the N-terminus of the target protein which can cause
undesired disabilities.
To construct the replicative expression vector pLIKE-
rep, again harboring PliaI(opt), the promoter fragment






n vector TM2064/TM1980 This work
vector TM1991/TM1992 This work
TM1981/TM1982 This work
TM1993/TM1994 This work
TM2130/ TM2131, TM1055/ TM1058 This work
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and XbaI, the promoter region was ligated into the cor-
responding sites of pGP380, resulting in vector pLIKE-
rep. For cloning of a gene into pLIKE-rep, XbaI must be
used as restriction enzyme to generate the ATG start
codon (see Figure 2).
For the determination of the properties of the two ex-
pression vectors, the genes gfpmut1 and ydfG were used.
The gfpmut1 gene was amplified using primers
TM1981/TM1982 and TM1993/TM1994, respectively
(Table 3), using plasmid pSG1151 as the template. The
720-bp amplicon obtained was cloned into ClaI/HindIII-
digested pLIKE-int or XbaI/SalI-digested pLIKE-rep,
resulting in translational fusions with PliaI(opt) in
pAT6203 and pAT3803, respectively (Table 4). Next, the
B. subtilis strains W168, TMB604, TMB1151, and
TMB1152 (Table 2) were transformed with the pAT6203
integrative plasmid. The resulting strains were desig-
nated TMB1172, TMB1174, TMB1153, TMB1318, re-
spectively (Table 2). Strains bearing the replicative
pAT3803 GFP-expression plasmid were constructed by
transformation of the above strains with plasmid DNA
and selection for MLS resistance, resulting in strains
TMB1176, TMB1178, TMB1342, and TMB1343, respect-
ively. The ydfG gene was amplified from Bacillus licheni-
formis genomic DNA using primers TM2545/TM2536
and TM2535/TM2536, respectively (Table 3). The PCR
product was cloned into ClaI/HindIII digested pLIKE-int
or XbaI/HindIII digested pLIKE-rep, resulting in plas-
mids pKSLIKEi01 and pKSLIKEr01, respectively
(Table 4). Next, the B. subtilis strain TMB1151 was
transformed with pKSLIKEr01 replicative plasmid and
TMB1152 was transformed with the linearized pKSLI-
KEi01 integrative plasmid, resulting in strains TMB1566
and TMB1570 (Table 2).
Activation of PliaI by bacitracin and analysis of gfp gene
expression
For bacitracin-mediated induction of gene expression,
the appropriate B. subtilis strains were inoculated from
overnight LB cultures into a final volume of 150 μL LB
medium in a 96-well plate with optical bottom (Sarstedt)
and were incubated in a Synergy™ 2 multimode micro-
plate reader (Biotek) at 37°C with constant medium
shaking. When the culture reached an OD600 of 0.45,
bacitracin (30 μg mL-1 final concentration) was added to
one half of the wells (induced sample), and the other half
was left untreated (uninduced control). Plates were cov-
ered with lids to prevent evaporation and incubated for
4 h. Growth was monitored by measuring absorbance at
600 nm. Fluorescence readings were taken from the bot-
tom by using a GFP-specific filter pair (excitation 485/20
nm, emission 528/20 nm). Measurements were taken in
10 min intervals. To calculate expression levels, thenatural fluorescence of three cultures of wild type B.
subtilis strain 168 (containing no reporter gene) were
averaged and subtracted from the raw fluorescence value
of each reporter strain at the same OD600 value [45]. De-
termination of PliaI activity was calculated as described
in [45] as the derivative of the fluorescence divided by
the OD600 (dGFP/dt/OD600) for each time point. Expres-
sion values were averaged from three independent sam-
ples of the same time points ((P1+P2+P3)/3). Polynomial
and exponential functions were used to fit the experi-
mental GFP dataset; promoter activities (dGFP/dt/
OD600) were calculated using these functions [45].Western blotting
Total cytoplasmic proteins were prepared from 15 mL
culture per time point by sonication. Proteins (20 μg per
lane) were separated by SDS-PAGE, according to stand-
ard procedure [42]. After electrophoresis and equilibra-
tion of the gels in transfer buffer [15.2 g Tris; 72.1 g
glycine; 750 mL methanol (100%) in a final volume of
5 L with deionized water] the proteins were blotted to a
PVDF membrane using a mini-trans blot apparatus (Bio-
Rad) according to standard procedure [42]. The LiaH
antibody (polyclonal rabbit antisera raised against puri-
fied His10–LiaH [46]), GFP antibody (rabbit monoclonal
antibody against the green fluorescent protein, Epi-
tomics), and the secondary antibody (anti-rabbit IgG
HRP conjugate, Promega) were diluted 1:20,000, 1:3,000,
and 1:100,000, respectively. For LiaH/GFP detection,
AceGlowTM (PeqLab) was used according to the manu-
facturer’s instructions. Blots were documented on a
QUANTUM-ST4-3026 chemiluminescence documenta-
tion system (PeqLab).Overproduction of YdfG
For the overexpression of ydfG, strains TMB1566 and
TMB1570 were grown in LB medium at 37°C until they
reached an OD600 of ~0.4-0.5. Cultures were split and
one half was induced with 30 μg ml-1 bacitracin for 30
min. The other half was left untreated. 20 ml of each
culture was harvested by centrifugation and cell pellets
were kept at −80°C until further use. For total protein
preparation, the cell pellets were resuspended in 1 ml of
cold disruption buffer (50 mM Tris–HCl, 100 mM NaCl,
pH 7.5) and cells were disrupted by sonication on ice.
Proteins (10 μg per lane) were separated by 14% tricine
SDS-PAGE, according to standard procedure [47] and
gels were subsequently stained by colloidale Coomassie
staining solution [48].Competing interests
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